BSEBoard Meeting3d ago · 11 Nov 2026, 04:47 pm
Dhampur Bio Organics Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2026 ,inter alia, to consider and approve 1. Audited Standalone and Consolidated Financial Results of the Company for the quarter and half year ended September 30, 2026 2. The proposal for buyback of equity shares of the Company and the matters necessary and incidental thereto, in accordance with the applicable provisions under ....
Dhampur Bio Organics Ltd · 543593
✦ AI SummaryResults
Dhampur Bio Organics Ltd has scheduled a Board Meeting on November 14, 2026 to consider and approve audited standalone and consolidated financial results for the quarter and half year ended September 30, 2026, and the proposal for buyback of equity shares.
Analysis Scores
Earnings Impact8/10
Growth Catalyst2/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk5/10
Liquidity Impact9/10
Market Sentiment5/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Dhampur Bio Organics Ltd - 543593 - Board Meeting Intimation for Approval Of Audited Standalone And Consolidated Financial Results Of The Company For The Quarter And Half Year Ended September 30, 2026 And The Proposal For Buyback Of Equity Shares Of The Company.
Attachments (1)
📄pdf
Download →
fbbcf654-893a-4c03-8995-06f6965d2843.pdf
View document text
Dhampur Bio Organics Ltd.
Date: November 11, 2026
The Manager – Listing The Manager – Listing
Dept of Corp. Services, National Stock Exchange of India Ltd.
BSE Limited Exchange plaza,Bandra Kurla Complex
P.J. Towers, Dalal Street, Fort, Bandra East
Mumbai – 400 001 Mumbai – 400 051
Scrip Code: 543593 Symbol: DBOL
Dear Sir/Mam,
Sub: Intimation of Board Meeting
Pursuant to Regulation 29 of the Securities & Exchange Board of India (Listing Obligations
and Disclosure Requirements) Regulations, 2015, Notice is hereby given that meeting of
Board of Directors of the Company is scheduled to be held on Saturday, November 14, 2026
to, inter-alia, consider the following:
1. Approval of audited Standalone and Consolidated Financial Results of the Company for
the quarter and half year ended on September 30, 2026.
2. The proposal for buyback of equity shares of the Company and the matters necessary
and incidental thereto, in accordance with the applicable provisions under Securities and
Exchange Board of India (Buy-back of Securities) Regulations, 2018, as amended, and
other applicable laws.
In continuation of our letter dated September 26, 2026, for closure of trading window for the
aforesaid purpose, the Trading Window for trading in Company’s securities will continue to
remain closed till November 16, 2026 pursuant to the Company’s "Code of Conduct” for
Prevention of Insider Trading.
Accordingly, all concerned to whom the above-said code is applicable are advised not to
trade in the Company’s securities during the period of closure of the Trading Window. The
Trading window will however be open for general investors.
You are requested to take the above information on record.
Thanking You
Your Sincerely,
For Dhampur Bio Organics Limited
Ashu Rawat
Company Secretary & Compliance Officer
Corp. Office: Second Floor, Plot No. 201, Okhla Industrial Estate, Phase III, New Delhi – 110 020, India, Tel: +91-11 – 6905 5200, Email: corporateoffice@dhampur.com, Website: www.dhampur.com
Regd. Office: Sugar Mill Compound, Village & Post – Asmoli, Distt. Sambhal, Uttar Pradesh – 244304, Tel: +91-7302318313
CIN : L15100UP2020PLC136939